Hanicki Z, Sułowicz W, Stepniewski M, Kuźniewski M, Kraśniak A, Kopeć J, Cieszkowska U, Solarska K
Kliniki Nefrologii AM w Krakowie.
Pol Arch Med Wewn. 1991 Jun;85(6):352-5.
Effect of intravenously administered recombinant human erythropoietin (rHu EPO) on haemoglobin (Hb) level, haematocrit (Ht), reticulocyte count and foetal haemoglobin (HbF) concentration was assessed in 10 patients with anaemia, treated by repeated haemodialysis due to end-stage kidney. As compared to the initial values, erythropoietin treatment brought about a significant increase in all the parameters examined. During the subsequent therapy with lower, supporting doses of erythropoietin, the elevated HbF values fell back to normal, whereas the higher level of total Hb and Ht were maintained.
对10例因终末期肾病接受反复血液透析治疗的贫血患者，评估静脉注射重组人促红细胞生成素（rHu EPO）对血红蛋白（Hb）水平、血细胞比容（Ht）、网织红细胞计数和胎儿血红蛋白（HbF）浓度的影响。与初始值相比，促红细胞生成素治疗使所有检测参数均显著增加。在随后使用较低维持剂量促红细胞生成素的治疗过程中，升高的HbF值回落至正常，而总Hb和Ht的较高水平得以维持。
